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Abstract
Monocyte-derived Langerhans cell-like dendritic cells （Mo-LCs） are involved in epidermal 
disorders such as psoriasis in murine models.  However, the roles of Mo-LCs in the 
pathogenesis of psoriasis in humans remain unclear.  Also, the contribution of notch ligand 
delta-like 1 （DLL-1）, expressed on keratinocytes, to Mo-LC functions requires clarification.  
Here, we established a new method of stimulating Mo-LCs derived from CD14＋ monocytes 
with immobilized human DLL-1 to generate induced Mo-LCs （DI（＋）Mo-LCs）.  The DI（＋）
Mo-LCs were compared to the dendritic cells derived from monocytes （Mo-DCs） cultured with 
interleukin-4 （IL-4） and granulocyte-macrophage colony-stimulating factor （GM-CSF）, and M1 
macrophages （Mφ） derived from monocytes cultured with GM-CSF.  The DI（＋）Mo-LCs were 
found to produce significant amounts of IL15, IL23A, and interferon-β （IFNB1） in response to 
the Toll-like receptor （TLR）3 agonist Polyinosinic-polycytidylic acid （Poly（I:C）） or TLR4 agonist 
lipopolysaccharide （LPS） despite their low expression of tumor necrosis factor （TNF）.  In 
conclusion, we have established a new method to generate DI（＋）Mo-LCs.  We have also 
discovered that DI（＋）Mo-LCs have a unique capacity for producing IL15 and IL23A, which are 
related to the pathogenesis of psoriasis.  Our data contribute to a better understanding of the 
roles of Mo-LCs in epidermal defense and pathogenesis.
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Introduction
　Langerhans cells （LCs） are the dendritic cells 
（DCs） of the epidermis; they originate from the 
stem cells that have moved to the epidermis during 
embryogenesis.  Recently, monocyte-derived LC-like 
dendritic cells （Mo-LCs） appearing during inflam-
mation have been reported1.  The Mo-LCs are 
involved in the pathogenesis of psoriasis, a chronic 
inflammatory skin disease, in some murine models2, 3. 
However, because the murine models cannot fully 
capture the complexity of human psoriasis lesions, 
the role of Mo-LCs in human psoriasis pathogenesis 
remains to be elucidated4.
　Although there are many methods of generating 
Mo-LCs5, 6, they produce Mo-LCs with different 
properties7-9.  Thus, the optimal method of Mo-LC 
generation remains unidentified.  Notch ligand delta-
like 1 （DLL-1）, a keratinocyte surface antigen, is 
expressed in the epidermis10 and known to promote 
LC differentiation.  Hoshino et al. established a 
method to generate Mo-LCs from peripheral blood 
monocytes via the initial stimulation with immobilized 
DLL-1, transforming growth factor-β1（TGF-β1）, 
and granulocyte-macrophage colony-stimulating 
factor （GM-CSF）11.  A model that conforms to 
the actual Mo-LC differentiation from inflammatory 
monocytes infiltrating into the epidermis is essential3, 
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and DLL-1-induced Mo-LCs （DI（＋）Mo-LCs） 
suit the model because DLL-1 is expressed in the 
epidermis.  Because DLL-1 affects the differentiation 
and function of some types of DCs12, 13, it can also 
have an essential role in the functions specific to 
Mo-LCs.  Also, DLL-1 is crucial for the monocyte 
differentiation into Mo-LCs.  The blockade of notch 
signaling was found to prevent the generation 
of LCs6, 11, and DLL-1 was found to inhibit the 
differentiation of monocytes to macrophages12. 
However, the specialized materials used for 
immobilizing DLL-1 are difficult to obtain; this may 
explain the small number of subsequent reports 
on DI（＋）Mo-LCs.  Thus, a different approach is 
required to facilitate further studies on DI（＋）
Mo-LCs.  Here, we present a new method of 
generating Mo-LCs from monocytes by immobilizing 
DLL-1 using uncoated plates with hydrophobic 
surfaces that were usually used for suspension cell 
culture.  This new method of DLL-1 immobilization 
was based on the method of attaching the first 
antibodies to uncoated plates in the general protocols 
of enzyme-linked immunosorbent assay （ELISA）. 
The new method was successful in producing DI（＋）
Mo-LCs sufficient for conducting experiment.
　Here, we have investigated the function of the DI
（＋）Mo-LCs and the relationship between DI（＋）
Mo-LCs and the pathogenesis of psoriasis.  We found 
unique characteristics of the DI（＋）Mo-LCs derived 
from CD14＋ peripheral blood monocytes in terms of 
cytokine expression following Toll-like receptor （TLR） 
stimulation, especially via TLR3 and TLR4.  These 
results agreed with the reports that the LCs and 
conventional DCs responded differently to TLR3 and 
TLR47-9.  Furthermore, these results showed that the 
DI（＋）Mo-LCs express interleukin-15 （IL15） and IL23A 
related to psoriasis pathogenesis upon TLR stimulation.
Materials and methods
Reagents
　Recombinant human （rh）DLL1 （BioLegend, San 
Diego, CA）, rhGM-CSF, rhTGF-β1, and rhIL-4 
（PeproTech, Cranbury, NJ） were purchased. 
Polyinosinic-polycytidylic acid （Poly（I:C））, lipopoly-
saccharide （LPS） from Escherichia coli （L4516）, and 
imiquimod （Sigma-Aldrich, St. Louis, MO） were 
procured.
Immobilizing DLL-1 and preparation of  Mo-LCs, 
monocyte-derived DCs （Mo-DCs）, and macrophages （Mφs）
　2 µg of DLL-1 dissolved in 2 ml of phosphate-
buffered saline （PBS） was added to uncoated 6-well 
plates （MS-8006R; SUMILON, Tokyo, Japan）, and 
the plates were centrifuged at 750 rpm for 2 hours 
at room temperature.  Coated 6-well plates with 
hydrophilic surfaces usually used for adherent cell 
cultures （#3516; Corning, Glendale, AZ） underwent 
the same treatment as a comparison.  The 
supernatant was then removed, and 10 µg of DLL-1 
dissolved in 1.25 ml of PBS was added.  The plates 
were then centrifuged at 750 rpm for 2 hours at room 
temperature and washed with PBS.
　Samples from 6 healthy volunteers were obtained 
after they signed an informed consent approved by 
the Ethics Committee of Showa University （Tokyo, 
Japan） （Approval number : 314）.  
　Peripheral blood mononuclear cells （PBMCs） 
were isolated from heparinized blood via Ficoll-
Paque （GE Healthcare, Chicago, IL） density gradient 
（1.077） centrifugation in Leucosep （Greiner Bio-
One, Kremsmünster, Austria）.  After the depletion of 
platelets, the CD14＋ monocytes were isolated using 
CD14 antibody （Ab）-conjugated magnetic microbeads 
（Miltenyi Biotec, Bergisch Gladbach, Germany） 
according to the manufacturer’s instructions.  The 
isolated CD14＋ monocytes （1×106cells/ml） were 
cultured in Roswell Park Memorial Institute （RPMI） 
1640 medium （FujiFilm Wako Pure Chemical 
Corporation, Osaka, Japan） supplemented with 10％ 
heat-inactivated fetal bovine serum （FBS） （GE 
Healthcare, Chicago, IL）, 100 U/ml penicillin G, 
100 µg/ml streptomycin （FujiFilm Wako Pure Chemical 
Corporation, Osaka, Japan）, GM-CSF, and TGF-β1 
for 7 days.  Human leukocyte antigen （HLA）-DR＋, 
langerin＋ cells, designated Mo-LCs, were isolated 
by fluorescence-activated cell sorting （FACS）.  The 
Mo-DCs were cultured with GM-CSF, IL-4, and 
the Mφs cultured with GM-CSF were used as the 
controls and sorted by FACS as HLA-DR＋, langerin－ 
cells.  All the cytokine concentrations were 10 ng/ml11.
FACS
　On day 7, the cells were adjusted to a concen-
tration of 3×106 cells/ml and incubated at 4°C for 40 
min with appropriate Abs.  After washing with ice-
cold PBS containing 0.2％ bovine serum albumin 
（BSA） and 2 mM ethylenediaminetetraacetic acid 
（EDTA）, the cells were analyzed on a FACSAria 
II using the FACSDiva software （Becton-Dickinson 
and Company, Franklin Lakes, NJ）.  The fluorescein 
isothiocyanate （FITC）-conjugated monoclonal antibody 
（mAb） to HLA-DR （clone L243）; allophycocyanin 
（APC）-labeled mAb to langerin （CD207, clone10E2）; 
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phycoerythrin （PE）-labeled mAb to TLR3 （clone 
TLR-104）; and Brilliant Violet （BV）421-labeled mAb 
to TLR4 （clone HTA125） （BioLegend, San Diego, 
CA） were used for flow cytometry.
The activation of Mo-LC, Mo-DC, and Mφ by TLR 
agonists
　The cells sorted by FACS were cultured in RPMI 
1640 medium supplemented with 10％ heat-inactivated 
FBS, 100 U/ml penicillin G, and 100 µg/ml streptomycin 
and in the presence or absence of 5 µg/ml of TLR3 
agonists Poly（I:C） or 1 µg/ml of TLR4 agonists LPS 
or 1 µg/ml TLR7/8 agonists imiquimod for 3 hours.
Quantitative real-time reverse transcription polymerase 
chain reaction （qRT-PCR）
　The qRT-PCR were performed using the 
StepOnePlus real-time PCR system （Applied Bio-
systems, Foster City, CA） with 5 ng of cDNA 
and TaqMan probes （Applied Biosystems, Foster 
City, CA） for TLR2 （primer set Hs00610101_
m1）, TLR3 （Hs01551078_m1）, TLR4 （Hs00152939_
m1）, TLR7 （Hs00152971_m1）, TLR8 （Hs00152972_
m1）, TLR9  （Hs0 0 152973_m1）, interferon-α 
（IFNA2） （Hs00265051_s1）, IFNB1 （Hs01077958_
s1）, IL1A （Hs00174092_m1）, IL1B （Hs01555410_
m1）, tumor necrosis factor （TNF） （Hs00174128_
m1）, IL6 （Hs00174131_m1）, IL15 （Hs01003716_
m1）, IL23A （Hs00372324_m1）, and β-actin （ACTB） 
（Hs99999903_m1）.  Results were normalized to 
ACTB, which acted as an endogenous reference, and 
the relative level of each messenger ribonucleic acid 
（mRNA） was calculated using the 2－ΔCT method.
Statistical analysis
　The unpaired Student’s t-test was performed using 
the JMP Pro 15 software for Windows （SAS Institute 
Inc., Cary, NC）.  A probability （p） value of less than 
0.05 was considered statistically significant.
Results
The effect of different DLL-1 treatment on the 
induction of Mo-LCs from monocytes
　We compared the percentage of Mo-LCs derived 
from the monocytes under three different treatments 
of DLL-1 （soluble, immobilized on coated plates, and 
immobilized on uncoated plates）.  The percentages of 
cells strongly positive for HLA-DR and langerin were 
higher when the monocytes were cultured with DLL-1 
immobilized on uncoated than coated plates （Figure 1A）. 
Similarly, the percentages of the langerin-positive 
Mo-LCs derived from the monocytes treated with 
DLL-1 immobilized on uncoated plates （14％-51％, 
p＜0.01） were significantly higher than those from 
the monocytes treated with soluble DLL-1 or DLL-1 
immobilized on coated plates （Figure 1B）.
Comparison of the levels of expression of the TLR 
genes and TLR proteins in DI（＋）Mo-LC, Mo-DC, 
and Mφ
　We compared the expression of TLR2, 3, 4, 7, 
8, and 9 in DI（＋）Mo-LCs, Mo-DCs, and Mφs 
using qRT-PCR （Figure 2A）.  Interestingly, TLR3 
expression was significantly higher in DI（＋）Mo-LCs 
than in Mo-DCs or Mφs （p＜0.01）, while there was 
no significant difference in the expression of other 
TLR genes.  The levels of TLR3 and TLR4 protein 
expression on the DI（＋）Mo-LCs were much lower 
than those on the Mo-DCs and Mφs, according to 
FACS analysis （Figure 2B）.
Fig. 1.   The comparison of the DI（＋）Mo-LCs （HLA-DR＋ 
langerin＋ cells） induced from monocytes by 
various methods
（A）  The comparison of the langerin＋ cells on the coated 
and uncoated plates. Two-color flow cytometry of the 
cultured cells was performed to measure langerin and 
HLA-DR. The numbers indicate the percentage of the 
HLA-DR＋ langerin＋ cells. Similar results were obtained 
with at least three different donors.
（B）  Non-immobilized : the cells were cultured in the presence 
of 50 ng/ml soluble DLL-1. Immobilized on coated 
plates : the cells were cultured on the coated plates 
whose hydrophilic surfaces were pretreated with DLL-1. 
Immobilized on uncoated plates : the cells were cultured 
on uncoated plates pretreated with DLL-1. After 7 
days of culture, the cells were analyzed by FACS. 
The samples were from at least three different donors. 
＊＊, p＜0.01.
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The comparison of cytokine expression stimulated by 
TLR3, TLR4, and TLR7/8 agonists
　Since the cells differed significantly in the levels 
of TLR3 and TLR4 （Figure 2）, we determined their 
cytokine expression in response to TLR3 （Poly（I:C）） 
and TLR4 （LPS） agonists （Figure 3）.  In addition, 
the TLR7/8 agonist （imiquimod）, used to induce 
psoriasis in the murine model, was examined.  The 
LPS-stimulated DI（＋）Mo-LCs expressed TNF, IL1B, 
and IL6 at significantly lower levels than the Mo-DCs 
and Mφs.  In contrast, the IL23A expression by 
the DI（＋）Mo-LCs was significantly higher than by 
the Mφs.  On the other hand, the IL15 expression 
by Poly（I:C） induction in the DI（＋）Mo-LCs was 
more robust than in the Mo-DCs （p＝0.0633） and 
significantly more than in the Mφs （p＜0.05）. 
Furthermore, the DI（＋）Mo-LCs expressed IFNB1 
at a significantly higher level than the Mo-DCs and 
Mφs （p＜0.05）.  Only a slight weak expression 
of IFNA2 and all these cytokines in responses to 
imiquimod （a TLR7/8 agonist） were observed in any 
of these cells （data not shown）.  Altogether, the 
three types of antigen-presenting cells studied in this 
report were found to respond to TLR3 and TLR4; 
however, they displayed different cytokine expression 
profiles when stimulated by TLR3 and TLR4.
Discussion
　The work presented here demonstrates for the first 
time that DI（＋）Mo-LCs can be induced by another 
method besides the original method11 and that DI
（＋）Mo-LCs express psoriasis-related cytokines, IL15 
and IL23A, upon stimulation by Poly（I:C） and LPS.
　In this study, we described the cytokine expression 
profile of the DI（＋）Mo-LCs since it has not 
been studied in detail.  We mainly compared the 
stimulation of the DI（＋）Mo-LCs, Mo-DCs, and Mφs 
by TLR3 and TLR4 ligands.  Unexpectedly, the DI
（＋）Mo-LCs had a significantly reduced level of 
TLR3 and, in particular, TLR4 on their surface 
membrane, while their expression TLR3 and TLR4 
were significantly higher than and equal to those in 
the Mo-DCs and Mφs, respectively.  The different 
results between qRT-PCR and FACS analysis 
（Figure 2） may be because mRNA expression is not 
necessarily correlated to protein production.  Also, 
the FACS analysis does not examine the intracellular 
TLRs but only the TLRs on the surface membrane. 
Thus, further studies are required to confirm these 
preliminary findings of the TLR levels.
　Our results showed that the DI（＋）Mo-LCs 
responded mainly to the TLR3 agonist and, to a 
Fig. 2.  The expression of the TLRs on Mo-LC, Mo-DC, and Mφ
（A）  The mRNA levels of TLR2, 3, 4, 7, 8, and 9 in DI（＋）Mo-LC, 
Mo-DC, and Mφ on day 7 were determined by qRT-PCR. The 
samples were from at least three different donors. ＊＊, p＜0.01.
（B）  The levels of TLR3 and TLR4 were determined by FACS. Two-color 
flow cytometry was performed for TLR3 and TLR4. The numbers 
indicate the percentage of each fraction. Similar results were 
obtained with at least three different donors.
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lesser extent, to the TLR4 agonist compared to 
the Mo-DCs and Mφs.  However, DI（＋）Mo-LCs’ 
substantial expression of IL15 and IL23A in response 
to LPS suggested that these cytokine expressions 
might be significant for the functions of the DI（＋）
Mo-LCs.  On the other hand, the TLR4-stimulated 
expression of TNF, IL1B, and IL6 by the DI（＋）
Mo-LCs was significantly lower than by the Mo-DCs 
or Mφs, which has been reported as a common 
feature of LC6, 14.  The differential response to TLR4 
among the cells in terms of cytokine expression 
was not explained by the loss of TLR4 on the DI
（＋）Mo-LCs.  Presumably, DLL-1 may affect the 
Mo-LCs in terms of their cytokine expression profile 
as well as the loss of TLR4.  The above results may 
suggest that the inflammatory monocytes infiltrated 
into the epidermis can retain the specific feature of 
the DI（＋）Mo-LCs at the epidermis where DLL-1 
is present10, 11, 15.  To date, numerous reports on the 
cytokine profiling of the LCs have used cord blood 
myeloid-progenitor-derived LC （rLC） or monocyte-
derived LC without using DLL-1 （DI（－）Mo-LC）7-9. 
According to these reports, there are similarities and 
differences between the DI（＋）Mo-LCs described 
Fig. 3.   The cytokine profiles of DI（＋）Mo-LC, Mo-DC, and Mφ. The expression 
of TNF, IL1A, IL1B, IL6, IL23A, IL15, and IFNB1 mRNA in Mo-LC, 
Mo-DC, and Mφ after activation by the TLR3 ligand Poly（I:C） or the 
TLR4 ligand LPS for 3 hours on day 7 was determined by qRT-PCR. 
The samples were from at least three different donors.  ＊, p＜0.05, 
＊＊, p＜0.01.
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here and the LCs from other sources.  We observed 
a substantially lower level of TLR4 on DI（＋）Mo-LC 
here, and Aar et al. reported low levels of TLR4 on 
the rLCs and DI（－）Mo-LCs14.  While the DI（＋）
Mo-LCs were found to express IL15 and IL23A after 
Poly（I:C） stimulation （Figure 3）, the expression of 
these cytokines were not detected by rLCs16.
　Our results raised the question of why DI（＋）
Mo-LC robustly expresses IL15 and IL23A but 
weakly expresses TNF in response to TLR4.  The 
variation in cytokine expression, which is dependent 
on the type of DCs, including LC, is complex. 
Some differences in the downstream signaling of 
TLR4 may have occurred during the individual 
differentiation of precursors into mature DCs.  Jurkin 
et al. reported a mechanism of DLL-1 in the drastic 
conversion of inflammatory DC into Mo-LC in 
the epidermis.  Namely, notch signaling by DLL-1 
in the keratinocytes represses kruppel-like factor 
4 （KLF4） in infiltrating inflammatory DCs, where 
KLF4 maintains the DC/macrophage phenotypes and 
depresses runt-related transcription factor 3 （RUNX3）, 
which is crucial for LC differentiation in response to 
TGF-β115.  Furthermore, it is reported that KLF4 or 
RUNX3 can regulate the expression of IL23A, IL15, 
IFNB1, and other pro-inflammatory cytokines17-20. 
These reports are partially consistent with our 
observation of the high expressions of IL23A, IL15, 
and IFNB1 and low expressions of pro-inflammatory 
cytokine genes by the DI（＋）Mo-LCs.  Since the 
effect of notch signaling on cytokine regulation can 
be complex, further detailed studies are necessary.
　Psoriasis, marked with well-demarcated patches of 
inflammation, is a common skin disease related to 
the immune system.  Because IL15 and IL23A are 
involved in the pathogenesis of epidermal lesions in 
psoriasis4, the cytokine profile of the DI（＋）Mo-LCs 
may have pathogenic roles in epidermal diseases. 
This result is consistent with Mo-LCs’ reported roles 
in psoriasis in the murine models2, 3.  While these 
murine models were induced by imiquimod, our 
results （Figure 3） showed that the DI（＋）Mo-LCs 
were stimulated more by Poly（I:C） and LPS than by 
imiquimod and that they could be involved in the 
pathogenesis of psoriasis in humans.  Although TLR3 
and TLR4 were reported as critical regulators of the 
inflammation of psoriasis21, the relationship between 
the pathogenesis of psoriasis and the stimulation of 
the Mo-LCs by TLR3 and TLR4 remains to be seen. 
Further studies using our new method to generate DI
（＋）Mo-LC might uncover this relationship.
Conclusions
　Using a newly established method to generate 
Mo-LCs, we found that the DI（＋）Mo-LCs had a 
unique capacity to produce cytokines related to the 
pathogenesis of psoriasis.  Our data contribute to 
a better understanding of the roles of Mo-LCs in 
epidermal pathogenesis.  Further studies using the 
procedures presented in this report will advance the 
research for chronic inflammatory skin disease.
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